netFormulary NHS
Pan Mersey
Area Prescribing Committee
 Formulary Chapter 3: Respiratory system - Full Section

Coronavirus guidance

Guidance to support primary care prescribers and pharmacists is available from the MLCSU Coronavirus guidance resource page. Links are provided to national resources and regional documents produced by MLCSU, RDTC, and SPS for use by Pan Mersey APC, LSCMMG, and GMMMG.

The list of resources will be updated as new material becomes available so please check back regularly for updates.

The Pan Mersey APC supports the use of COVID-specific guidance issued by NICE, and NHS England and NHS Improvement. During the COVID pandemic this will supersede any APC advice.

Respiratory system

Review date: March 2022

Non-formulary drugs: Any drug or formulation not listed in the formulary is deemed to be non-formulary.

Off-label use: Drugs are included in the formulary for their licensed indications – where inclusion of off-label use is considered to be included in the formulary this is specifically stated in the formulary entry for the drug N.B. also see Paediatrics note below.

Paediatrics: Drugs are included in the formulary for paediatric use for their BNF for Children recommended indications (indicated by symbol View childrens BNF) which may be off-label, unless otherwise stated. All drugs are deemed to have the same RAG status as they have for adults unless stated otherwise.

NHS England Specialised Commissioning
Drugs carrying the NHS England logo are commissioned by them. Links to key documents, national programmes of care, and clinical reference groups are found below.

NHSE NHS England Specialised Commissioning: Key documents

NHSE NHS England Specialised Commissioning: National programmes of care and clinical reference groups

 Useful Links

03.01 Bronchodilators
03.01.01 Adrenoceptor agonists Selective Beta2 agonists
Short-acting beta2 agonists
Long-acting beta2 agonists Other adrenoceptor agonists
03.01.02 Antimuscarinic bronchodilators
03.01.03 Theophylline
03.01.04 Compound bronchodilator preparations
03.01.05 Peak flow meters, inhaler devices and nebulisers
Peak flow meters
Drug delivery devices
Nebuliser Diluent
03.02 Corticosteroids
03.03 Cromoglicate, related therapy and leukotriene receptor antagonists
03.03.01 Cromoglicate and related therapy
03.03.02 Leukotriene receptor antagonists
03.03.03 Phosphodiesterase type-4 inhibitors
03.04 Antihistamines, hyposensitisation, and allergic emergencies
03.04.01 Antihistamines
Non-sedating antihistamines
Sedating antihistamines
03.04.02 Allergen Immunotherapy
Mepolizumab & Omalizumab
03.04.03 Allergic emergencies
03.05 Respiratory stimulants and pulmonary surfactants
03.05.01 Respiratory stimulants
03.05.02 Pulmonary surfactants
03.06 Oxygen
Long-term oxygen therapy
Short burst oxygen therpary
Ambulatory oxygen therapy
Oxygen therapy equipment
Arrangements for supplying oxygen
03.07 Mucolytics
03.08 Aromatic inhalations
03.09 Cough preparations
03.09.01 Cough suppressants
03.09.02 Expectorant and demulcent cough preparations
03.10 Systemic nasal decongestants
03.11 Antifibrotics